PRQR
ProQR Therapeut (PRQR)
NASDAQ
$1.91+$0.05 (+2.69%)
Price as of Sep 11, 2026 7:58 PM EDT
  • $195.7M
    Market Cap
  • -15.07%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ADAGE CAPITAL PARTNERS GP, L.L.C.
8.56%
9.0M
+2.8M (+30.64%)
Jun 30, 2026
ABRDN PLC
8.48%
8.9M
+5.6M (+62.87%)
Jun 30, 2026
RTW INVESTMENTS, LLC
6.67%
7.0M
+584,612 (+8.32%)
Dec 31, 2021
RTW INVESTMENTS, LP
6.67%
7.0M
-8,115 (-0.12%)
Mar 31, 2022
AFFINITY ASSET ADVISORS, LLC
5.26%
5.5M
+3.1M (+55.73%)
Jun 30, 2026
PRIVIUM FUND MANAGEMENT B.V.
5.24%
5.5M
+52,875 (+0.96%)
Jun 30, 2026
PRIVIUM FUND MANAGEMENT (UK) LTD
4.53%
4.8M
+4.8M (+100.00%)
Dec 31, 2021

Current Ownership Distribution

  • Institutions580.9M (86.85%)
  • Mutual Funds85.8M (12.82%)
  • Insiders2.2M (0.32%)
  • Other0 (0.00%)

Insider Transactions

  • 0.32% (2.2M)
    Current InsiderOwnership (%, shares)
  • 2
    Number of InsiderBuying (last 12 months)
  • $1.0M
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
de Boer Daniel Anton
Chief Executive Officer
Buy
Jul 31, 2026
$353,960.00
200,000
$1.77
500,000
Filius Bart
Buy
Jul 17, 2026
$257,925.00
150,000
$1.72
300,000
de Boer Daniel Anton
Chief Executive Officer
Buy
Jul 09, 2026
$261,000.00
150,000
$1.74
300,000
Filius Bart
Buy
Jun 26, 2026
$231,000.00
150,000
$1.54
150,000